Clinical significance of baseline and post-treatment CXCR1 expression in breast cancer women received neoadjuvant chemotherapy
Objective: To examine the chemokine receptor type 1 expression in breast cancer tissues before and after neoadjuvant chemotherapy, and its relationship with pathological response to neoadjuvant chemotherapy and other clinical variables. Methods: The prospective study was conducted at Kafrelsheikh U...
Main Authors: | Sara Adel Amin, Emad Abd El Mongy Sadaka, Khalid Ahmed Ismail, Ashraf Fathy Barakat, Ahmed Abdel Aziem Menaisy, Amr Abd Elmoneim Mahmoud |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2023-05-01
|
Series: | Journal of the Pakistan Medical Association |
Subjects: | |
Online Access: | https://ojs.jpma.org.pk/index.php/public_html/article/view/9856 |
Similar Items
-
Relation between baseline CXCR1 expression and neoadjuvant chemotherapy response in breast cancer patients
by: Sara Adel Amin, et al.
Published: (2023-05-01) -
Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer
by: Elżbieta Pawluczuk, et al.
Published: (2021-10-01) -
Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
by: Ala Litman-Zawadzka, et al.
Published: (2020-08-01) -
Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study
by: Jie Yang, et al.
Published: (2024-04-01) -
Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
by: Haidi Abd El Zaher, et al.
Published: (2023-10-01)